Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety

Transfusion Medicine Reviews

Volumn 25, Issue 4, 2011, Pages 267-292

  Leach Bennett, Judie ^a,b   Blajchman, Morris A ^a,b   Delage, Gilles ^a,b   Fearon, Margaret ^a,b   Devine, Dana ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b HÉMA QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD SAFETY; BLOOD TRANSFUSION; CANADA; CONSENSUS; DECISION MAKING; DRUG MARKETING; FRANCE; GERMANY; HEALTH ECONOMICS; HEALTH HAZARD; HUMAN; MEDICAL ETHICS; PATIENT CARE; POLICY; PUBLIC HEALTH; RISK ASSESSMENT; RISK MANAGEMENT; UNITED KINGDOM; UNITED STATES;

ACADEMIES AND INSTITUTES; BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CANADA; DECISION MAKING; EUROPEAN UNION; HUMANS; MASS SCREENING; MODELS, THEORETICAL; RISK; RISK MANAGEMENT; RISK REDUCTION BEHAVIOR; TRUTH DISCLOSURE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; UNITED STATES NATIONAL AERONAUTICS AND SPACE ADMINISTRATION;

EID: 80052866913     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.05.002     Document Type: Article

References (36)

1. US Department of Health and Human Services, National Institutes of Health (NIH) Consensus Development Program, Kensington, MD. Available at: http://consensus.nih.gov/aboutcdp.htm.
2. Consensus Statement: International Consensus Conference on Risk-based Decision Making for Blood Safety, Vox Sang, in press.
3. Commission of Inquiry on the Blood System in Canada, Final Report of the Commission of Inquiry on the Blood System in Canada (Ottawa: Public Works and Government Services Canada, 1997) at 1013, 1048-1049, 1072.
4. Mintz P.D. On target, but there's no magic bullet. Am J Clin Path 2001, 116:802-805.
5. Memorandum of Understanding executed by the Federal, Provincial and Territorial Ministers of Health, Canada, 1997.
6. Clarke P., Ghani A. Projections of the future course of the primary vCJD epidemic in the UK: Inclusion of subclinical infection and the possibility of wider genetic susceptibility. JR Soc Interface 2005, 2:19-31.
7. Gelineau G: Rapport du comité québécois sur l'approvisionnement, la gestion et la distribution du sang. Bibliothèque nationale du Québec, 1996 ISBN 2-551-17199-7, 2006.
8. Robillard P., Nawej K.I., Jochem K. The Quebec hemovigilance system: Description and results from the first two years. Transfus Apheresis Sci 2004, 31:111-122.
9. Robillard P., Brottet E., Karl Itaj N. Positive impact of online inter-hospital consultation of transfusion history on incidence of red cell ABO mistransfusions, acute and delayed hemolytic transfusion reactions. Transfusion 2006, 46(Suppl. 9S):13A-14A.
10. Robillard P., Delage G., Nawej K.I., et al. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection. Transfusion 2011, [Epub ahead of print]. 10.1111/j.1537-2995.2010.03001.x.
11. The blood safety and quality regulations Available at:. http://www.opsi.gov.uk/si/si2005/20050050.htm.
12. Chapman C.E., Stainsby D., Jones H., et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. LM; Serious Hazards of Transfusion Steering Group. Transfusion 2009, 49:440-452.
13. Cohen H., Mold D., Jones H., et al. The 2009 annual SHOT report 2010, on behalf of the Serious Hazards of Transfusion Steering Group. C. Taylor (Ed.).
14. National Patient Safety Agency: Safer Practice Notice No. 14, November 2006.
15. Williamson L.M., Stainsby D., Jones H., et al. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host. Transfusion 2007, 47:1455-1467.
16. British Committee for Standards in Haematology, Blood Transfusion Task Force Guidelines on the use of irradiated blood components. Br J Haematol 2011, 35-51. http://www.bcshguidelines.com/documents/Irradiation_BJH_2011.pdf.
17. Chaffe B., Jones J., Milkins C., et al. UK Transfusion Laboratory Collaborative: Recommended minimum standards for hospital transfusion laboratories. Transfusion 2009, 19:156-158.
18. Chaffe B., Jones J., Milkins C., et al. Recommended minimum standards for hospital transfusion laboratories-UK Transfusion Laboratory Collaborative. Biomed Sci 2010, 54:711-712. http://www.ibms.org/includes/act_download.php?download=UK-trans-Recommended-Standards.pdf.
19. With data and contributions from Laurent Bardiauxof EtablissementFrançais du Sang Bourgogne Franche-Comté, Besançon, France.
20. The Alliance of Blood Operators (ABO) is a working group comprised of six blood systems: Canadian Blood Services, America's Blood Centers, American Red Cross, Australian Red Cross Blood Service, NHS Blood and Transplant (UK) (NHSBT), and the European Blood Alliance.
21. ISO 31000 standard: Risk management-Principles and guidelines 2009, International Organization for Standardization, Switzerland.
22. Shortreed J. ERM frameworks. Enterprise risk management-Today's leading research and best practices for tomorrow's executives 2010, 97-123. John Wiley & Sons, Inc., Hoboken, NJ. J. Fraser, B. Simkins (Eds.).
23. CAN/CSA-ISO 31000-10 (ISO 31000:2009, IDT) risk management-Principles and guidelines 2010, Canadian Standards Association, Standards Council of Canada, Ottawa, Canada.
24. Leiss W., Tyshenko M., Krewski D. Men having sex with men donor deferral risk assessment: An analysis using risk management principles. Transfus Med Rev 2008, 22:35-57.
25. Canadian Blood Services v. Freeman, 2004 CanLII 35007 (ON S.C.).
26. Attributed to Captain 1930, British Aviation Insurance Group, London. A.G. Lamplugh (Ed.).
27. US42 United States Code chapter 6A.
28. US21 Federal Food, Drug and Cosmetic Act.
29. US21 Code of Federal Regulations.
30. Janssen M.P., Over J., van der Poel C.L., et al. A probabilistic model for analyzing viral risks of plasma-derived medicinal products. Transfusion 2008, 48:153-162.
31. Janssen M.P., Cator E.A., van der Poel C.L., et al. Monitoring viral incidence rates: Tools for the implementation of European Union regulations. Vox Sang 2009, 96:298-308.
32. Sugarman J., Devine D.V. Ethical principles in transfusion medicine. Policy alternatives in transfusion medicine 2001, 19-41. AABB Press, Bethesda (Md). J.P. Aubuchon, L.D. Petz, A. Fink (Eds.).
33. Beyond consent: Seeking justice in research 1998, Oxford University Press, New York, NY. J.P. Kahn, A.M. Mastroianni, J. Sugarman (Eds.).
34. Sugarman J. Informed consent for research: historical, ethical, and policy issues. Informed consent in blood transfusion and cellular therapies 2007, 139-146. AABB Press, Bethesda, MD. C. Stowell, K. Sazama (Eds.).
35. Commission of the European Communities: Communication of the Commission on the Precautionary Principle, Brussels 2.2.2000 (COM 2000 1 final).
36. Agapova M., Busch P., Custer B. Cost-effectiveness of screening the US blood supply for trypanosomacruzi. Transfusion 2010, 50:2220-2232.